Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia.

Journal of clinical lipidology - 1 Jan 2000

Harris Leonard J, Thapa Rashmi, Brown Michael, Pabbathi Sabitha, Childress Richard D, Heimberg Murray, Braden Ron, Elam Marshall B

Abstract excerpt

BACKGROUND: Muscle pain without elevation of serum creatine phosphokinase (CPK) (myalgia) is the most common medication-related adverse effect of statin therapy; it occurs in up to 10% of patients who are prescribed statin therapy. Although much is known regarding risk factors for overt myositis, very few studies have provided information on this common form of statin intolerance. METHODS: We defined a detailed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Creatine Kinase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Hyperlipidemias

Share to Muscular Diseases

Share to Myositis

Source

Identifiers

PMID: 21784376
DOI: 10.1016/j.jacl.2011.05.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia.PMID 21784376Read ↗

A common missense variant of LILRB5 is associated with statin intolerance and myalgia.Semantic proximity Read ↗

Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.Semantic proximity Read ↗

Patients experiencing statin-induced myalgia exhibit a unique program of skeletal muscle gene expression following statin re-challenge.Semantic proximity Read ↗

Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.Semantic proximity Read ↗

Genetic predisposition to statin myopathy.Semantic proximity Read ↗

The genetics of statin-induced myopathy.Semantic proximity Read ↗

Phenotype standardization for statin-induced myotoxicity.Semantic proximity Read ↗

Clinical characterization and molecular mechanisms of statin myopathy.Semantic proximity Read ↗

Mechanisms of statin-induced myalgia assessed by physiogenomic associations.Semantic proximity Read ↗

Iatrogenic myopathies.Semantic proximity Read ↗

Genetic and immunologic susceptibility to statin-related myopathy.Semantic proximity Read ↗

Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle ComponentsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.